Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Abroad (travel likely)Recruiting
Conditions
Pancreatic Cancer · Benign Pancreatic Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (William R Jarnagin, MD)
Study leads
William Jarnagin, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center